
United States · research
CellSight is developing a suite of PET tracers targeted at visualizing immune response early in a patient's immunotherapy regimen.
PrivateFor profit
Set against 1,463 research companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 0% of those with a size listed; older than 40% of those with a founding year; website ranked #9,013,678 in the world, about 445 visits a month.
BiotechnologyHealth Care
One of 1,463 research companies in United States, and of 3,254 in the industry worldwide.
What the source datasets report. We have not watched these rounds ourselves.
Undisclosed
raised in total across 1 round
Last raised Jul 2016, 10 years ago
Who started it and how it trades.
Everything the source datasets list about CellSight Technologies, field by field. Contact details are held but never shown.
The company7 fields
Where3 fields
Size and reach3 fields
Funding, as listed5 fields
About this record2 fields
Growth, as the source summarises it
CellSight Technologies may be growing as indicated by its inclusion in a list of companies receiving research funding, which suggests an influx of capital that can be used for development and expansion efforts. The company operates in the biotechnology and health care industries, which are experiencing technological advancements and favorable regulatory environments, potentially benefiting CellSight Technologies. Furthermore, the association with GE Healthcare Technologies in a news article implies a level of collaboration or recognition within the industry, which could be indicative of the company's increasing presence or reputation in the market.
1,463 research companies in United States, filtered by size, age and reach, ready to export with emails on Pro.